SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-20-005862
Filing Date
2020-08-12
Accepted
2020-08-12 16:35:25
Documents
5
Effectiveness Date
2020-08-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 s8_081220.htm S-8 55823
2 EXHIBIT 5.1 exh_51.htm EX-5.1 8271
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2809
4 EXHIBIT 99.1 exh_991.htm EX-99.1 91683
5 GRAPHIC footer.jpg GRAPHIC 5921
  Complete submission text file 0001171843-20-005862.txt   167911
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-245024 | Film No.: 201095890
SIC: 2836 Biological Products, (No Diagnostic Substances)